tiprankstipranks

Galmed signs binding term-sheet with Entomus for development of SEDDS

Galmed (GLMD) Pharmaceuticals announced that it has signed a binding term-sheet with Entomus s.r.o. for a license agreement for the development and commercialization of a proprietary Self-Emulsifying Drug Delivery System formulation that allows absorption of sublingually administrated peptides such as GLP-1. A definitive agreement determining, among other things, the milestones payments and future royalty payments is to be executed within ninety days.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue